ArticlePLoS computational biology2026
AddaGCN: Spatial transcriptomics deconvolution using graph convolutional networks with adversarial discriminative domain adaptation.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The rapid advancement of spatial transcriptomics has substantially improved our understanding of the spatial architecture and gene expression heterogeneity within tissues. However, many spatial transcriptomics techniques can not reach single-cell resolution, instead measuring gene expression profiles from mixtures of potentially heterogeneous cell types. Here we propose AddaGCN, a robust deconvolution method to infer cell type composition from spatial transcriptomic data. AddaGCN leverages graph convolutional networks to incorporate spatial information and adopts an adversarial discriminative domain adaptation approach to mitigate batch effects between spatial and single-cell reference data. Comprehensive analyses of real data generated by diverse technology platforms demonstrate AddaGCN's superior performance and robustness in cell-type deconvolution compared to other methods. These analyses further reveal AddaGCN's potential to uncover spatiotemporal changes during tissue development and to characterize the tumor microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.